Breaking News

Bhawanipur Global Campus Announces iNATCONPH 2026: A Global Platform for Pharmacy & Allied Health Research

Kolkata: Bhawanipur Global Campus has announced the 16th International Conference - iNATCONPH 2026, a prestigious international scientific conference that will be held on 8–9 October 2026 in Kolkata. The...

Emcure Pharma Receives CDSCO Approval to Launch Poviztra®️ for Fatty Liver Disease Treatment

Emcure Pharmaceuticals Ltd  announced that its co-marketed semaglutide brand, Poviztra®, has received regulatory approval from the Central Drugs...

CDSCO Partners with THSTI to Strengthen Vaccine and Healthcare innovation

The Central Drugs Standard Control Organization (CDSCO), India’s national regulatory authority, and the Translational Health Science and Technology...

EMeRG Launches Hospital Intel Suite™️ to transform MedTech Market

EMeRG, a leading healthcare intelligence provider with over a decade of industry expertise,  announced the launch of Hospital...

CDSCO Issues Final Guidance for Medical Device Software Under MDR 2017

The Central Drugs Standard Control Organisation (CDSCO), functioning under the Directorate General of Health Services, Ministry of Health...

Merck Launches Industry-First Bio-Based Solvent Portfolio for (HPLC)

In a significant step toward greener laboratory practices, Merck Group has launched the industry’s first bio-based solvent portfolio designed specifically for high-performance liquid chromatography...

Eli Lilly Expands Oncology Pipeline with Kelonia Buyout, Targets Next-Gen CAR-T Therapy

In a strategic move set to reshape the future of cancer treatment, Eli Lilly and Company has announced its acquisition of Kelonia Therapeutics in...

Novo Nordisk’s Etavopivat Cracks Phase 3 Goals: A Potential New Standard of Care for Sickle Cell Disease

Novo Nordisk’s Etavopivat hits the mark in Pivotal Sickle Cell Study. Etavopivat, an oral, once-daily pyruvate kinase-R (PKR) activator displayed supercilious results showing 27%...

CDSCO Directs Stakeholders to Submit Prior Intimation for BA/BE Studies Online via Sugam Portal

In a significant regulatory development, the Central Drug Standard Control Organization, (CDSCO) has issued a circular mandating stakeholders to submit prior intimation for...

NIPER Mohali Partners with Novartis to Advance Industry–Academia Collaboration

By Dose Daily News Bureau 20th April, 2026 19:00 PM IST The National Institute of Pharmaceutical Education and Research (NIPER) Mohali, has signed a formal collaboration...